Clozapine and Psychosocial Function in Schizophrenia: A Systematic Review and Meta-Analysis

CNS Drugs
Andrew T OlagunjuBernhard T Baune

Abstract

Clozapine has unique efficacy for symptoms in treatment-resistant schizophrenia; however, symptomatic remission is not necessary nor sufficient for functional improvement. No study has pooled the effect of clozapine on psychosocial function across clinical trials. We conducted a systematic review and meta-analysis to compare the effects of clozapine with other antipsychotics on psychosocial function, and described the predictors of functional outcome. We searched MEDLINE/PubMed, PsychINFO, EMBASE, CINAHL, Scopus, Web of Science, Cochrane Central Register of controlled trials and clinical trial registries till April 2018, with no language limits. Eligible studies were randomised controlled trials of clozapine vs. typical or atypical antipsychotics among adults with treatment-resistant schizophrenia. We included studies with flexible or fixed doses of antipsychotics within the therapeutic range to reflect naturalistic care. Effect sizes of studies were pooled using generic inverse variance and random-effects models and presented as standard mean differences. Study quality was assessed in accordance with the Cochrane Collaboration guideline, and subgroup analyses were carried out to identify potential moderators and methodological...Continue Reading

References

Dec 1, 1972·Archives of General Psychiatry·J S Strauss, W T Carpenter
Jan 1, 1983·Schizophrenia Bulletin·I R Falloon, R P Liberman
Jan 1, 1984·Schizophrenia Bulletin·D W HeinrichsW T Carpenter
Apr 1, 1983·Archives of General Psychiatry·A F Lehman
Jun 1, 1995·The American Journal of Psychiatry·W T CarpenterC A Tamminga
Dec 1, 1994·The American Journal of Psychiatry·J A LiebermanJ M Kane
Dec 1, 1993·Hospital & Community Psychiatry·A BreierW T Carpenter
Jan 1, 1994·Journal of the American Academy of Child and Adolescent Psychiatry·T MozesA Weizman
Jul 15, 1993·The New England Journal of Medicine·J M AlvirJ A Schaaf
Jul 14, 1999·Psychiatric Services : a Journal of the American Psychiatric Association·A PintoL DeSimone
Dec 1, 1999·Comprehensive Psychiatry·W W Shen
Feb 7, 2001·The British Journal of Psychiatry : the Journal of Mental Science·M MarshallM Fenton
Oct 21, 2000·Progress in Neuro-psychopharmacology & Biological Psychiatry·K WahlbeckR Rimón
Apr 11, 2001·Schizophrenia Research·R A GouldD Goff
Aug 2, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Joanna Moncrieff
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Jul 29, 2004·Schizophrenia Bulletin·Anthony F LehmanDonald M Steinwachs
Mar 7, 2006·Clinical Neuropharmacology·Fayçal MouaffakDavid Gourion
Jun 8, 2006·Psychological Medicine·N M MenezesR B Zipursky
Aug 15, 2006·Schizophrenia Bulletin·Mario PfammatterHans Dieter Brenner
Oct 19, 2007·Acta Psychiatrica Scandinavica·T Burns, D Patrick
Nov 21, 2007·The British Journal of Psychiatry. Supplement·Tom Burns
Jan 29, 2008·Expert Opinion on Pharmacotherapy·Nitin Gogtay, Judith Rapoport
May 3, 2008·The American Journal of Psychiatry·Somaia MohamedRichard S E Keefe
May 16, 2008·Epidemiologic Reviews·John McGrathJoy Welham
Aug 19, 2008·BMC Medical Research Methodology·Jianbing MaWeiya Zhang
Jan 30, 2009·Schizophrenia Bulletin·Robert S KernStephen R Marder
May 7, 2009·Current Opinion in Psychiatry·Richard Warner
Jul 23, 2009·Annals of Internal Medicine·David MoherUNKNOWN PRISMA Group
Sep 2, 2009·Psychological Assessment·Eunyoe Ro, Lee Anna Clark
Dec 4, 2009·Schizophrenia Bulletin·Lisa B DixonUNKNOWN Schizophrenia Patient Outcomes Research Team (PORT)
Dec 10, 2009·The Journal of Nervous and Mental Disease·Eliza Martha de Paiva BarrettoHelio Elkis
Jul 21, 2010·Clinical Schizophrenia & Related Psychoses·Christina Wilson, Alvin V Terry
Feb 9, 2011·Archives of General Psychiatry·Beng-Choon HoVincent Magnotta
May 4, 2011·Acta Psychiatrica Scandinavica·J NielsenD Taylor

❮ Previous
Next ❯

Citations

Apr 9, 2019·The Australian and New Zealand Journal of Psychiatry·Andrew T OlagunjuBernhard T Baune
Sep 24, 2021·Translational Psychiatry·Elias WagnerAlkomiet Hasan
Dec 29, 2021·Acta Psychiatrica Scandinavica·Alexander Panickacheril JohnAjay Velayudhan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here